Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/NABRIVA THERAPEUTICS PLC/ 15-12G

SEC Filing · 15-12G

NABRIVA THERAPEUTICS PLC

SEC Filing

Filed Oct 25, 2023Accepted Oct 25, 2023, 9:43 AM EDTCIK 1641640Accession 0001104659-23-111352
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
NBRVOTC · EQUITY · Historical · closed Jul 31, 2023

Recent company filings

  1. EFFECT filingOct 24, 2023
  2. POS AM filingOct 20, 2023
  3. S-8 POS filingOct 20, 2023
  4. S-8 POS filingOct 20, 2023
  5. S-8 POS filingOct 20, 2023

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗